Strategies to Improve Long Term Islet Graft Survival.

Trial Profile

Strategies to Improve Long Term Islet Graft Survival.

Completed
Phase of Trial: Phase II

Latest Information Update: 28 Apr 2016

At a glance

  • Drugs Lisofylline (Primary) ; Antithymocyte globulin; Basiliximab; Sirolimus; Tacrolimus
  • Indications Islet cell transplant rejection; Type 1 diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 18 Jun 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
    • 12 Jan 2012 Actual patient number is 5 according to ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top